Overview
- IndustryElectromedical & Electrotherapeutic Apparatus2
- HeadquartersMiddleton, United States2
- Incorporated inDE3
- Business address3150 Pleasant View Road, Middleton, Wi 535623
- Filer categoryLarge accelerated filer3
- Legal formCorporation2
- LEI549300ZW3JLSJGT2D8382
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O The Corporation Trust Company, 19801 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 32626362
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Research and development12¢$56.3M
- Other costs84¢$395.9M
- Interest0¢$1.9M
- Income tax1¢$6.2M
- Profit3¢$13.2M
Out of $473.4M in revenue.4
Where each dollar of operating cash went, fiscal 2021
- Capital spending6¢$3.6M
- Kept or used elsewhere94¢$60.4M
Out of $64.0M of cash from operations.4
Financial statements
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $375.9M5 | $381.9M6 | $501.0M7 | $530.9M8 | $495.2M4 | $415.7M4 | $473.4M4 |
| Cost of revenue | $145.5M5 | $144.6M5 | $213.4M5 | $218.0M7 | $196.6M7 | ||
| Gross profit | $227.5M5 | $234.9M6 | $281.2M7 | $304.0M8 | $291.7M4 | $216.5M4 | $273.7M4 |
| Research and development | $30.4M5 | $33.4M6 | $51.8M7 | $61.5M8 | $58.7M4 | $61.3M4 | $56.3M4 |
| Operating expenses | $249.9M4 | ||||||
| Operating income | $53.5M5 | $55.3M6 | $8.7M7 | -$24.6M8 | -$15.7M4 | -$20.2M4 | $23.8M4 |
| Interest | $352.0K5 | $430.0K6 | $5.1M7 | $6.8M8 | $4.9M4 | $3.7M4 | $1.9M4 |
| Income before tax | $19.4M4 | ||||||
| Income tax | $14.5M5 | $12.3M6 | $25.4M7 | -$9.3M8 | -$5.6M4 | -$5.5M4 | $6.2M4 |
| Net income | $37.9M5 | $42.6M6 | -$20.3M7 | -$22.9M8 | -$15.7M4 | -$16.6M4 | $13.2M4 |
| Earnings per share | $1.175 | $1.316 | -$0.627 | -$0.698 | -$0.474 | -$0.494 | $0.394 |
| Earnings per share (diluted) | $1.145 | $1.296 | -$0.627 | -$0.698 | -$0.474 | -$0.494 | $0.394 |
| Shares (weighted, basic) | 33.7M shares4 | ||||||
| Shares (weighted, diluted) | 34.0M shares4 |
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $82.5M6 | $213.6M7 | $89.0M8 | $56.4M4 | $63.3M4 | $82.1M4 | $75.6M4 |
| Receivables | $111.8M4 | ||||||
| Inventory | $67.7M4 | ||||||
| Current assets | $241.4M10 | $405.8M5 | $305.6M6 | $285.8M7 | $269.7M8 | $271.7M4 | $277.3M4 |
| Property, plant and equipment | $21.8M4 | ||||||
| Goodwill | $148.7M4 | ||||||
| Intangible assets | $65.5M4 | ||||||
| Total assets | $479.5M10 | $649.0M5 | $709.9M6 | $638.1M7 | $622.5M8 | $600.4M4 | $564.3M4 |
| Accounts payable | $36.4M4 | ||||||
| Short-term debt | $04 | ||||||
| Current liabilities | $77.1M10 | $79.9M5 | $92.1M6 | $133.4M7 | $142.8M8 | $145.8M4 | $114.6M4 |
| Long-term debt | $010 | $140.0M5 | $154.3M6 | $69.5M7 | $19.7M8 | $5.8M4 | $04 |
| Total liabilities | $88.8M10 | $231.6M5 | $287.8M6 | $239.7M7 | $206.4M8 | $189.3M4 | $139.5M4 |
| Retained earnings | $84.5M4 | ||||||
| Shareholders’ equity | $390.7M6 | $417.4M7 | $422.1M8 | $398.4M4 | $416.1M4 | $411.1M4 | $424.8M4 |
| Shares outstanding | 33.2M shares10 | 32.9M shares5 | 33.1M shares6 | 33.8M shares7 | 34.1M shares8 | 33.9M shares4 | 34.2M shares4 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash from operations | $36.9M5 | $72.7M6 | $19.7M7 | $33.0M8 | $60.1M4 | $34.4M4 | $64.0M4 |
| Depreciation and amortization | $28.1M4 | ||||||
| Stock-based compensation | $14.2M4 | ||||||
| Capital spending | $4.1M5 | $3.2M6 | $4.1M7 | $7.9M8 | $5.3M4 | $8.6M4 | $3.6M4 |
| Free cash flow | $32.8M | $69.5M | $15.7M | $25.1M | $54.7M | $25.8M | $60.4M |
| Cash from investing | -$1.9M4 | ||||||
| Share buybacks | $11.5M5 | $19.3M6 | $2.3M7 | $5.6M8 | $04 | $10.5M4 | $04 |
| Cash from financing | -$60.7M4 |
Corporate structure
NATUS MEDICAL INC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of NATUS MEDICAL INC
- VANGUARD GROUP INC Filed SC 13G/A on NATUS MEDICAL INC, latest Feb 10, 2022
- VICTORY CAPITAL MANAGEMENT INC Filed SC 13G/A on NATUS MEDICAL INC, latest Feb 2, 2022
- Allspring Global Investments Holdings, LLC Filed SC 13G on NATUS MEDICAL INC, latest Jan 19, 2022
- NATUS MEDICAL INC Middleton, Wisconsin, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What NATUS MEDICAL INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $55.1M4 Dec 31, 2021 | $55.2M4 Dec 31, 2020 | −0.3% |
| Accumulated depreciation | $33.3M4 Dec 31, 2021 | $30.7M4 Dec 31, 2020 | +8.4% |
| Property and equipment, net | $21.8M4 Dec 31, 2021 | $24.5M4 Dec 31, 2020 | −11.1% |
| Finance-lease assets | $2.4M4 Dec 31, 2021 | $2.6M4 Dec 31, 2020 | −7.8% |
| Operating-lease assets (leased space) | $9.3M4 Dec 31, 2021 | $11.7M4 Dec 31, 2020 | −20.4% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $148.7M4 Dec 31, 2021 | $151.3M4 Dec 31, 2020 | −1.7% |
| Intangible assets, net (excluding goodwill) | $65.5M4 Dec 31, 2021 | $92.7M4 Dec 31, 2020 | −29.4% |
| Finite-lived intangibles, gross | $252.1M4 Dec 31, 2021 | $271.0M4 Dec 31, 2020 | −7.0% |
| Accumulated amortization | $177.1M4 Dec 31, 2021 | $164.0M4 Dec 31, 2020 | +8.0% |
| Finite-lived intangibles, net | $65.5M4 Dec 31, 2021 | $90.7M4 Dec 31, 2020 | −27.8% |
Inventory
Leadership
Who has led NATUS MEDICAL INC, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerThomas Joseph Sullivan Jan 4, 2022 to Jul 21, 202211
- Chief executive officerCarsten Buhl Apr 12, 2018 to Apr 12, 201812
- Chief executive officerJames B. Hawkins Mar 10, 2006 to May 2, 201813
- PresidentThomas Joseph Sullivan Jan 4, 2022 to Jul 21, 202211
- PresidentCarsten Buhl Apr 12, 2018 to Apr 12, 201812
- PresidentJohn T. Buhler Feb 16, 2011 to Feb 21, 201314
- PresidentJames B. Hawkins Mar 10, 2006 to May 2, 201813
- Chief financial officerSharon Villaverde Jul 26, 2018 to Jul 26, 201815
- Chief financial officerBenjamin Drew Davies Oct 3, 2018 to Jul 21, 202216
- Chief operating officerJohn T. Buhler Feb 16, 2011 to Feb 21, 201314
Board members and other officers (18)
- VP/GM Newborn CareLeslie L. McDonnell Feb 22, 2018 to Feb 22, 201817
- Vice President Medical AffairsDong Chune Christopher Chung Jun 19, 2006 to Jul 21, 202218
- VP Marketing and SalesKenneth M. Traverso Jun 19, 2006 to Jan 5, 201719
- Vice President OperationsWilliam L. Mince Jun 19, 2006 to Dec 13, 201220
- Board memberBryant M. Moore Aug 20, 2021 to Jul 21, 202221
- Board memberEric Guerin Aug 20, 2021 to Jul 21, 202222
- Board memberIlan Daskal Mar 20, 2020 to Jul 21, 202223
- Board memberAlice D. Schroeder Feb 13, 2019 to Jul 21, 202224
- Board memberThomas Joseph Sullivan Feb 14, 2019 to Jul 21, 202225
- Board memberJoshua Levine Jul 5, 2018 to Jul 21, 202226
- Board memberLisa Wipperman Heine Jul 5, 2018 to Jul 21, 202227
- Board memberBarbara R. Paul Sep 23, 2016 to Jun 21, 202128
- Board memberRobert A. Gunst Feb 27, 2006 to May 2, 201929
- Board memberJames B. Hawkins Mar 10, 2006 to May 2, 201813
- Board memberKen Ludlum Mar 27, 2006 to Aug 2, 201930
- Board memberDoris Engibous Jun 19, 2006 to Jun 8, 201831
- Board memberMark D. Michael Jun 19, 2006 to Jun 11, 201332
- Board memberWilliam M. Moore Jun 19, 2006 to May 18, 201833
Timeline
- Jul 21, 20228-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer34
- Jul 7, 20228-K Shareholder vote35
- Jun 15, 20228-K Shareholder vote36
- May 5, 20228-K Results of operations37
- Apr 18, 20228-K Entered a material agreement; Executive or director change; Other events38
- Feb 24, 20228-K Results of operations; Executive or director change39
- Jan 10, 20228-K Results of operations40
- Jan 4, 2022New chief executive Thomas Joseph Sullivan becomes CEO11
- Dec 17, 20218-K Executive or director change41
- Nov 4, 20218-K Results of operations42
- Apr 12, 2018New chief executive Carsten Buhl becomes CEO12
- Mar 10, 2006New chief executive James B. Hawkins becomes CEO13
- Jul 20, 2000Founded NATUS MEDICAL INC is founded2
Calendar
When it reported results
- May 5, 2022Reported quarterly or annual results37
- Feb 24, 2022Reported quarterly or annual results39
- Jan 10, 2022Reported quarterly or annual results40
- Nov 4, 2021Reported quarterly or annual results42
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
62 filings to the SEC since October 2021: 1 annual reports, 2 quarterly reports, 9 major events, 25 insider forms, 5 large holders, 20 other. The latest 20:
- Aug 1, 202215-12G EDGAR
- Jul 22, 2022EFFECT EDGAR
- Jul 22, 2022EFFECT EDGAR
- Jul 22, 2022EFFECT EDGAR
- Jul 21, 202225-NSE EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 20224 EDGAR
- Jul 21, 2022S-8 POS EDGAR
- Jul 21, 2022S-8 POS EDGAR
- Jul 21, 2022S-8 POS EDGAR
- Jul 21, 2022S-8 POS EDGAR
- Jul 21, 2022S-8 POS EDGAR
The 62 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
1 open-market trades by officers, directors and large owners since October 2021: 0 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 9, 2021 | CHUNG DONG CHUNE CHRISTOPHERChief Medical Officer | Sale | 11,787 | $23.08 | $272.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- VANGUARD GROUP INCSC 13G/A, 1 filing Feb 10, 202243
- VICTORY CAPITAL MANAGEMENT INCSC 13G/A, 1 filing Feb 2, 202244
- Allspring Global Investments Holdings, LLCSC 13G, 1 filing Jan 19, 202245
SEC filer profile
How NATUS MEDICAL INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARNATUS MEDICAL INC1
- CIK0000878526
- Employer ID (EIN)77-01548331
- Filer statusLarge accelerated filer1
- Incorporated inDelaware1
- Fiscal year endsDecember 311
- Industry code (SIC)3845 Electromedical & Electrotherapeutic Apparatus1
- Business address3150 Pleasant View Road, Middleton, WI 535621
- Phone60882985001
- Shares outstanding34,585,114 as of Apr 29, 20229
- Public float$886.8M as of Jun 30, 20214
- On EDGAR sinceAug 18, 20001
- Filings1,227 in all: 4 (565), 8-K (220), SC 13G/A (66), 10-Q (63), SC 13G (31), DEFA14A (26), 3 (23), SC 13D/A (22)1
All 50 form types
10-K (20), 4/A (20), DEF 14A (20), 5 (17), UPLOAD (15), 8-K/A (12), 10-K/A (8), CORRESP (8), DFAN14A (8), S-1/A (7), DEFR14A (5), EFFECT (5), S-8 (5), S-8 POS (5), SD (5), 424B5 (4), SC 13D (4), DEFC14A (3), NT 10-K (3), POS AM (3), PRER14A (3), S-3 (3), S-3/A (3), 8-A12G (2), 8-A12G/A (2), ARS (2), NT 10-Q (2), PRE 14A (2), PREC14A (2), 10-K405 (1), 10-Q/A (1), 15-12G (1), 25-NSE (1), 424B2 (1), 424B4 (1), 5/A (1), DEFM14A (1), PREM14A (1), PRRN14A (1), RW (1), S-1 (1), S-1MEF (1)
- Latest filingsAnnual report (10-K) Feb 25, 2022
Quarterly report (10-Q) May 6, 2022
Proxy statement (DEF 14A) Apr 28, 2022
Latest 8-K (8-K) Jul 21, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARJohn T. Buhler, President
- 15
- 16
- 17
- 18
- 19
- 20
- 21SEC EDGARBryant M. Moore, Board member
- 22SEC EDGAREric Guerin, Board member
- 23SEC EDGARIlan Daskal, Board member
- 24SEC EDGARAlice D. Schroeder, Board member
- 25SEC EDGARThomas Joseph Sullivan, Board member
- 26SEC EDGARJoshua Levine, Board member
- 27SEC EDGARLisa Wipperman Heine, Board member
- 28SEC EDGARBarbara R. Paul, Board member
- 29SEC EDGARRobert A. Gunst, Board member
- 30SEC EDGARKen Ludlum, Board member
- 31SEC EDGARDoris Engibous, Board member
- 32SEC EDGARMark D. Michael, Board member
- 33SEC EDGARWilliam M. Moore, Board member
- 34
- 35SEC EDGARShareholder vote
- 36SEC EDGARShareholder vote
- 37SEC EDGARResults of operations
- 38
- 39
- 40SEC EDGARResults of operations
- 41SEC EDGARExecutive or director change
- 42SEC EDGARResults of operations
- 43
- 44
- 45